Andrew Stolz

7.2k total citations · 1 hit paper
97 papers, 3.6k citations indexed

About

Andrew Stolz is a scholar working on Pharmacology, Oncology and Epidemiology. According to data from OpenAlex, Andrew Stolz has authored 97 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pharmacology, 30 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Andrew Stolz's work include Drug-Induced Hepatotoxicity and Protection (37 papers), Drug Transport and Resistance Mechanisms (29 papers) and Pharmacogenetics and Drug Metabolism (26 papers). Andrew Stolz is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (37 papers), Drug Transport and Resistance Mechanisms (29 papers) and Pharmacogenetics and Drug Metabolism (26 papers). Andrew Stolz collaborates with scholars based in United States, United Kingdom and Japan. Andrew Stolz's co-authors include Robert J. Fontana, Neil Kaplowitz, Huiman X. Barnhart, Hajime Takikawa, Paul H. Hayashi, K. Rajender Reddy, José Serrano, David E. Kleiner, Victor J. Navarro and Jay H. Hoofnagle and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Andrew Stolz

90 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network

2014 292 citations Victor J. Navarro, Huiman X. Barnhart et al. Hepatology profile →

Peers

Andrew Stolz

PHARM

ONCOL

EPIDE

Nathan J. Cherrington United States

Marcelo G. Roma Argentina

Huichang Bi China

Masahiro Tohkin Japan

Alain Berson France

S S Thorgeirsson United States

Jonathan Maher United States

Rommel G. Tirona Canada

Paul A. Dawson United States

Mitchell R. McGill United States

Nathan J. Cherrington United States

Andrew Stolz

1.1k ×0.7

PHARM

2.2k ×2.3

ONCOL

1.5k ×1.9

EPIDE

1.3k ×1.9

213 ×0.4

Citations per year, relative to Andrew Stolz Andrew Stolz (= 1×) peers Nathan J. Cherrington

Countries citing papers authored by Andrew Stolz

Since Specialization

Citations

This map shows the geographic impact of Andrew Stolz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Stolz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Stolz more than expected).

Fields of papers citing papers by Andrew Stolz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Stolz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Stolz. The network helps show where Andrew Stolz may publish in the future.

Co-authorship network of co-authors of Andrew Stolz

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Stolz. A scholar is included among the top collaborators of Andrew Stolz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Stolz. Andrew Stolz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yi‐Ju, Jawad Ahmad, Huiman X. Barnhart, et al.. (2024). Clinical characteristics and HLA associations of azithromycin‐induced liver injury. Alimentary Pharmacology & Therapeutics. 60(6). 787–795. 7 indexed citations

Hayashi, Paul H., et al.. (2024). Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database. The American Journal of Gastroenterology. 120(6). 1307–1313. 3 indexed citations

Magnan, Chr̀istophe, Andrew Stolz, John A. Tayek, et al.. (2024). Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning. SHILAP Revista de lepidopterología. 3(2). e0000447–e0000447. 4 indexed citations

Argemí, Josepmaria, Marina Gritsenko, Ana Clemente, et al.. (2022). Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis. American Journal Of Pathology. 192(12). 1658–1669. 8 indexed citations

Nicoletti, Paola, Andrew Dellinger, Yi‐Ju Li, et al.. (2022). Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate. Gastroenterology. 164(3). 454–466. 25 indexed citations

Stolz, Andrew. (2022). Newly identified genetic variants associated with idiosyncratic drug-induced liver injury. Current Opinion in Gastroenterology. 38(3). 230–238. 6 indexed citations

Chen, Chien-Yu, Yang Li, Ni Zeng, et al.. (2021). Inhibition of Estrogen-Related Receptor α Blocks Liver Steatosis and Steatohepatitis and Attenuates Triglyceride Biosynthesis. American Journal Of Pathology. 191(7). 1240–1254. 21 indexed citations

Kamal, Natasha, Christopher Koh, Niharika Samala, et al.. (2019). Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis. Hepatology International. 13(5). 641–648. 36 indexed citations

Schmeltzer, Paul A., Andrzej S. Kosinski, David E. Kleiner, et al.. (2015). Liver injury from nonsteroidal anti‐inflammatory drugs in the United States. Liver International. 36(4). 603–609. 67 indexed citations

10.

Martínez, Melissa, Raj Vuppalanchi, Robert J. Fontana, et al.. (2015). Clinical and histologic features of azithromycin-induced liver injury. Carolina Digital Repository (University of North Carolina at Chapel Hill). 7 indexed citations

11.

Navarro, Victor J., Huiman X. Barnhart, Herbert L. Bonkovsky, et al.. (2014). Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 60(4). 1399–1408. 292 indexed citations breakdown →

12.

Martínez, Melissa, Raj Vuppalanchi, Robert J. Fontana, et al.. (2014). Clinical and Histologic Features of Azithromycin-Induced Liver Injury. Clinical Gastroenterology and Hepatology. 13(2). 369–376.e3. 94 indexed citations

13.

Ji, Qing, Lilly Chang, Frank Z. Stanczyk, et al.. (2007). Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling. Cancer Research. 67(3). 1361–1369. 52 indexed citations

14.

Stolz, Andrew, et al.. (2006). Increasing AKR1C1 and AKR1C2 dependent DHT catabolism in prostate cancer (CaP) cell lines by Phase II Inducers can prevent DHT-dependent gene expression: implications for chemoprevention of CaP. Cancer Research. 66. 99–99.

15.

Lou, Huan, Shouying Du, Qing Ji, & Andrew Stolz. (2006). Induction of AKR1C2 by Phase II Inducers: Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF2. Molecular Pharmacology. 69(5). 1662–1672. 86 indexed citations

16.

Lou, Huan, Murad Ookhtens, Andrew Stolz, & Neil Kaplowitz. (2003). Chelerythrine stimulates GSH transport by rat Mrp2 (Abcc2) expressed in canine kidney cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 285(6). G1335–G1344. 21 indexed citations

17.

Ji, Qing, et al.. (2003). Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. The Prostate. 54(4). 275–289. 72 indexed citations

18.

Bahar, Ron & Andrew Stolz. (1999). BILE ACID TRANSPORT. Gastroenterology Clinics of North America. 28(1). 27–58. 59 indexed citations

19.

Gartung, Carsten, et al.. (1996). Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology. 110(1). 199–209. 214 indexed citations

20.

Takikawa, Hajime, Andrew Stolz, Syoji Kuroki, & Neil Kaplowitz. (1990). Oxidation and reduction of bile acid precursors by rat hepatic 3α-hydroxysteroid dehydrogenase and inhibition by bile acids and indomethacin. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1043(2). 153–156. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact